STOCK TITAN

MarineMax US Financials

HZO
FY2025 annual
Revenue $2.3B -5.0% YoY
Net Income -$31.6M -183.1% YoY
EPS (Diluted) -$1.43 -186.7% YoY
Free Cash Flow $11.9M +113.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

MarineMax US (HZO) reported $2.3B in revenue for fiscal year 2025, down 5.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HZO FY2025

Inventory-led working capital swings and a heavier debt load now shape results more than modest changes in sales.

Profit and cash stopped moving together: the company produced $147.3M of cumulative net income while free cash flow totaled -$373.7M over the same stretch, even though reported earnings stayed positive for much of it. With inventory expansion absorbing cash, the balance sheet became the main operating bottleneck; the latest year's return to positive free cash flow despite a net loss implies that pressure eased only when working capital stopped expanding.

Core merchandise economics held up better than final earnings: gross margin moved from 34.9% at its recent peak to 32.5% in the latest year. The sharper squeeze happened below gross profit, where operating margin fell from 11.5% to 1.5%, so the earnings problem looks more like cost absorption and financing drag than a collapse in gross spread.

Financing costs are now part of the business model, not a footnote: debt-to-equity rose from 0.1x to 0.4x over the last few years. That shift helps explain why interest expense expanded from $3.3M to $71.2M, materially narrowing the room between operating income and bottom-line profit.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 35 / 100
Financial Health Score 35/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of MarineMax US's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
52

MarineMax US has an operating margin of 1.5%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 52/100, indicating healthy but not exceptional operating efficiency. This is down from 5.3% the prior year.

Growth
26

MarineMax US's revenue declined 5.0% year-over-year, from $2.4B to $2.3B. This contraction results in a growth score of 26/100.

Leverage
28

MarineMax US has elevated debt relative to equity (D/E of 0.38), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.

Liquidity
28

MarineMax US's current ratio of 1.20 is below the typical benchmark, resulting in a score of 28/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
22

While MarineMax US generated $72.8M in operating cash flow, capex of $60.9M consumed most of it, leaving $11.9M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.

Returns
52

MarineMax US posts a -3.4% return on equity (ROE), meaning it loses $3 for every $100 of shareholders' equity. This results in a returns score of 52/100. This is down from 3.9% the prior year.

Altman Z-Score Grey Zone
1.95

MarineMax US scores 1.95, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

MarineMax US passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

MarineMax US reported a net loss of $31.6M while generating $72.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
0.48x

MarineMax US earns $0.48 in operating income for every $1 of interest expense ($34.0M vs $71.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.3B
YoY-5.0%
5Y CAGR+8.9%
10Y CAGR+11.9%

MarineMax US generated $2.3B in revenue in fiscal year 2025. This represents a decrease of 5.0% from the prior year.

EBITDA
$83.3M
YoY-51.7%
5Y CAGR-7.0%
10Y CAGR+9.6%

MarineMax US's EBITDA was $83.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 51.7% from the prior year.

Net Income
-$31.6M
YoY-183.1%

MarineMax US reported -$31.6M in net income in fiscal year 2025. This represents a decrease of 183.1% from the prior year.

EPS (Diluted)
-$1.43
YoY-186.7%

MarineMax US earned -$1.43 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 186.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$11.9M
YoY+113.9%
5Y CAGR-47.2%

MarineMax US generated $11.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 113.9% from the prior year.

Cash & Debt
$170.4M
YoY-24.1%
5Y CAGR+1.8%
10Y CAGR+18.0%

MarineMax US held $170.4M in cash against $356.2M in long-term debt as of fiscal year 2025.

Shares Outstanding
22M
YoY-3.2%
5Y CAGR0.0%
10Y CAGR-1.0%

MarineMax US had 22M shares outstanding in fiscal year 2025. This represents a decrease of 3.2% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
32.5%
YoY-0.5pp
5Y CAGR+6.1pp
10Y CAGR+7.9pp

MarineMax US's gross margin was 32.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the prior year.

Operating Margin
1.5%
YoY-3.8pp
5Y CAGR-5.6pp
10Y CAGR-1.9pp

MarineMax US's operating margin was 1.5% in fiscal year 2025, reflecting core business profitability. This is down 3.8 percentage points from the prior year.

Net Margin
-1.4%
YoY-2.9pp
5Y CAGR-6.3pp
10Y CAGR-7.8pp

MarineMax US's net profit margin was -1.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.9 percentage points from the prior year.

Return on Equity
-3.4%
YoY-7.3pp
5Y CAGR-19.8pp
10Y CAGR-20.4pp

MarineMax US's ROE was -3.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 7.3 percentage points from the prior year.

Capital Allocation

Share Buybacks
$27.5M
YoY+1183.5%

MarineMax US spent $27.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1183.5% from the prior year.

Capital Expenditures
$60.9M
YoY+0.7%
5Y CAGR+36.6%
10Y CAGR+20.1%

MarineMax US invested $60.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.7% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

HZO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HZO annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$2.2B$2.3B-5.0%$2.4B+1.5%$2.4B+3.8%$2.3B+11.9%$2.1B+36.7%$1.5B+22.0%$1.2B+5.1%$1.2B+11.9%$1.1B+11.7%$942.0M+25.4%$751.4M+20.3%$624.7M+6.9%$584.5M+11.4%$524.5M+9.1%$480.9M
Cost of Revenue$1.4B$1.6B-4.3%$1.6B+4.5%$1.6B+3.8%$1.5B+7.0%$1.4B+26.4%$1.1B+21.5%$914.3M+4.0%$879.1M+11.7%$787.0M+9.9%$716.0M+26.4%$566.6M+22.4%$462.9M+6.7%$433.6M+10.9%$391.2M+8.2%$361.4M
Gross Profit$751.3M$750.2M-6.4%$801.2M-4.1%$835.3M+3.7%$805.8M+22.2%$659.4M+65.4%$398.7M+23.5%$322.8M+8.2%$298.2M+12.4%$265.3M+17.4%$226.0M+22.3%$184.8M+14.2%$161.8M+7.3%$150.9M+13.2%$133.3M+11.5%$119.5M
SG&A Expenses$684.5M$647.2M-3.8%$673.0M+6.1%$634.5M+17.4%$540.5M+20.1%$450.0M+54.1%$292.0M+11.3%$262.3M+11.6%$235.1M+6.8%$220.0M+18.4%$185.8M+16.5%$159.4M+8.9%$146.4M+10.5%$132.5M+3.6%$127.9M0.0%$127.9M
Operating Income$66.8M$34.0M-73.5%$128.2M-36.1%$200.8M-24.3%$265.2M+26.6%$209.5M+96.3%$106.7M+76.3%$60.5M-4.2%$63.2M+39.5%$45.3M+12.5%$40.3M+58.9%$25.3M+64.6%$15.4M-16.1%$18.3M+241.7%$5.4M+163.9%-$8.4M
Interest Expense$62.1M$71.2M-3.7%$73.9M+38.5%$53.4M+1525.6%$3.3M-10.4%$3.7M-60.5%$9.3M-19.9%$11.6M+16.9%$9.9M+32.4%$7.5M+37.0%$5.5M+22.6%$4.5M+10.7%$4.0M-4.6%$4.2M-5.1%$4.4M+27.5%$3.5M
Income Tax-$57K-$6.4M-140.9%$15.6M-58.9%$38.0M-40.6%$63.9M+25.8%$50.8M+122.8%$22.8M+75.9%$13.0M-7.2%$14.0M-2.1%$14.3M+16.8%$12.2M+144.5%-$27.4M-30225.3%$91K+110.2%-$894K-408.0%-$176K+52.0%-$367K
Net Income$4.0M-$31.6M-183.1%$38.1M-65.2%$109.3M-44.8%$198.0M+27.8%$155.0M+107.7%$74.6M+107.4%$36.0M-8.5%$39.3M+67.0%$23.5M+4.3%$22.6M-53.2%$48.3M+328.4%$11.3M-25.0%$15.0M+1267.1%$1.1M+109.5%-$11.5M
EPS (Diluted)-$1.43-186.7%$1.65-66.1%$4.87-44.9%$8.84+30.4%$6.78+101.2%$3.37+114.6%$1.57-8.2%$1.71+80.0%$0.95+4.4%$0.91-52.6%$1.92+317.4%$0.46-27.0%$0.63+1160.0%$0.05+109.6%-$0.52

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

HZO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HZO annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$2.5B-5.2%$2.6B+7.6%$2.4B+79.0%$1.4B+34.2%$1.0B+30.0%$775.3M-1.1%$784.1M+22.4%$640.5M+0.1%$640.0M+17.1%$546.7M+16.9%$467.6M+16.1%$402.7M+5.4%$381.9M+4.6%$365.1M+0.5%$363.1M
Current Assets$1.2B-7.3%$1.3B+13.4%$1.1B+49.0%$754.0M+45.7%$517.5M+2.8%$503.3M-11.5%$568.6M+22.2%$465.3M-1.8%$473.8M+21.1%$391.1M+16.5%$335.8M+16.2%$289.0M+4.7%$276.1M+5.1%$262.6M+1.9%$257.8M
Cash & Equivalents$170.4M-24.1%$224.3M+11.4%$201.5M-11.7%$228.3M+2.7%$222.2M+42.9%$155.5M+303.8%$38.5M-21.1%$48.8M+16.4%$42.0M+8.7%$38.6M+18.3%$32.6M+17.1%$27.8M+17.2%$23.8M+0.6%$23.6M+21.8%$19.4M
Inventory$867.3M-4.3%$906.6M+11.5%$812.8M+78.9%$454.4M+96.7%$231.0M-22.5%$298.0M-37.6%$477.5M+26.6%$377.1M-6.0%$401.3M+24.6%$322.0M+17.6%$273.9M+12.2%$244.2M+7.1%$228.0M+6.0%$215.1M-2.1%$219.6M
Accounts Receivable$108.3M+1.8%$106.4M+24.0%$85.8M+70.6%$50.3M+5.5%$47.7M+18.5%$40.2M-5.2%$42.4M+24.7%$34.0M+37.9%$24.7M+0.3%$24.6M+33.1%$18.5M+47.2%$12.5M-35.4%$19.4M+3.1%$18.8M+32.9%$14.2M
Goodwill$526.9M-11.0%$592.3M+5.8%$559.8M+137.6%$235.6M+20.5%$195.6M+132.1%$84.2M+31.6%$64.0M+133.6%$27.4M+5.8%$25.9M+161.6%$9.9M+1134.4%$802K0.0%$802K0.0%$802K+77.4%$452KN/A
Total Liabilities$1.5B-6.0%$1.6B+7.7%$1.5B+163.6%$570.1M+38.1%$412.9M+29.1%$319.9M-23.0%$415.3M+44.5%$287.4M-14.9%$337.8M+44.2%$234.2M+27.3%$184.0M+12.6%$163.4M+2.1%$160.1M-2.5%$164.2M-2.4%$168.1M
Current Liabilities$984.9M-7.9%$1.1B+26.2%$847.0M+105.2%$412.8M+64.4%$251.1M-7.9%$272.5M-34.0%$412.9M+44.4%$286.0M-14.5%$334.7M+44.3%$231.9M+26.4%$183.4M+12.6%$162.8M+2.0%$159.6M-0.8%$160.9M-0.8%$162.2M
Long-Term Debt$356.2M+0.1%$355.9M-8.6%$389.2M+759.2%$45.3M-4.6%$47.5M+546.8%$7.3M$0$0$0$0$0$0$0$0N/A
Total Equity$937.2M-4.0%$975.8M+6.5%$915.8M+17.0%$782.7M+31.6%$594.9M+30.6%$455.4M+23.5%$368.8M+4.5%$353.1M+16.8%$302.2M-3.3%$312.5M+10.2%$283.6M+18.5%$239.3M+7.9%$221.8M+10.4%$200.9M+3.0%$195.0M
Retained Earnings$746.4M-4.1%$778.0M+5.1%$739.9M+17.3%$630.7M+45.8%$432.7M+55.8%$277.7M+37.2%$202.5M+21.9%$166.1M+31.0%$126.8M+22.8%$103.2M+36.8%$75.4M+177.9%$27.1M+71.0%$15.9M+1778.0%$845K+432.7%-$254K

HZO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HZO annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$219.0M$72.8M+383.7%-$25.7M+88.5%-$222.2M-390.1%$76.6M-79.5%$373.9M+22.7%$304.7M+2551.9%-$12.4M-117.6%$70.4M+1384.0%$4.7M-79.2%$22.9M+645.0%$3.1M-71.6%$10.8M+38.4%$7.8M-9.9%$8.7M+159.1%-$14.7M
Capital Expenditures$41.0M$60.9M+0.7%$60.4M-7.6%$65.4M+11.9%$58.5M+123.8%$26.1M+104.0%$12.8M-24.9%$17.1M+23.6%$13.8M-3.9%$14.4M+11.3%$12.9M+32.5%$9.7M+6.0%$9.2M-6.4%$9.8M+71.4%$5.7M-13.0%$6.6M
Free Cash Flow$178.0M$11.9M+113.9%-$86.1M+70.1%-$287.6M-1685.8%$18.1M-94.8%$347.8M+19.1%$291.9M+1089.8%-$29.5M-152.1%$56.6M+688.3%-$9.6M-196.7%$9.9M+249.0%-$6.7M-513.4%$1.6M+180.3%-$2.0M-168.4%$2.9M+113.8%-$21.3M
Investing Cash Flow-$26.9M-$55.6M+31.6%-$81.3M+85.9%-$576.4M-310.4%-$140.5M+12.8%-$161.1M-435.2%-$30.1M+46.6%-$56.3M-141.6%-$23.3M+27.4%-$32.1M-7.9%-$29.7MN/AN/A-$12.6M-64.9%-$7.6M+12.1%-$8.7M
Financing Cash Flow-$168.1M-$72.0M-156.0%$128.5M-83.3%$770.4M+954.4%$73.1M+150.1%-$145.7M+7.8%-$158.1M-369.7%$58.6M+245.7%-$40.2M-231.0%$30.7M+138.9%$12.9MN/AN/A$4.9M+54.2%$3.2M-87.8%$26.2M
Share BuybacksN/A$27.5M+1183.5%$2.1MN/A$21.3M-10.4%$23.8M+3666.9%$631K-97.7%$27.7M+3886.8%$695K-98.4%$42.7M+672.7%$5.5M-47.2%$10.5MN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

HZO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HZO annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin32.5%-0.5pp33.0%-1.9pp34.9%0.0pp34.9%+3.0pp32.0%+5.5pp26.4%+0.3pp26.1%+0.8pp25.3%+0.1pp25.2%+1.2pp24.0%-0.6pp24.6%-1.3pp25.9%+0.1pp25.8%+0.4pp25.4%+0.6pp24.9%
Operating Margin1.5%-3.8pp5.3%-3.1pp8.4%-3.1pp11.5%+1.3pp10.2%+3.1pp7.1%+2.2pp4.9%-0.5pp5.4%+1.1pp4.3%0.0pp4.3%+0.9pp3.4%+0.9pp2.5%-0.7pp3.1%+2.1pp1.0%+2.8pp-1.8%
Net Margin-1.4%-2.9pp1.6%-3.0pp4.6%-4.0pp8.6%+1.1pp7.5%+2.6pp4.9%+2.0pp2.9%-0.4pp3.3%+1.1pp2.2%-0.2pp2.4%-4.0pp6.4%+4.6pp1.8%-0.8pp2.6%+2.4pp0.2%+2.6pp-2.4%
Return on Equity-3.4%-7.3pp3.9%-8.0pp11.9%-13.4pp25.3%-0.8pp26.1%+9.7pp16.4%+6.6pp9.8%-1.4pp11.1%+3.3pp7.8%+0.6pp7.2%-9.8pp17.0%+12.3pp4.7%-2.1pp6.8%+6.2pp0.5%+6.5pp-5.9%
Return on Assets-1.3%-2.7pp1.5%-3.0pp4.5%-10.1pp14.6%-0.7pp15.4%+5.8pp9.6%+5.0pp4.6%-1.6pp6.1%+2.5pp3.7%-0.5pp4.1%-6.2pp10.3%+7.5pp2.8%-1.1pp3.9%+3.6pp0.3%+3.5pp-3.2%
Current Ratio1.200.0x1.19-0.1x1.33-0.5x1.83-0.2x2.06+0.2x1.85+0.5x1.38-0.2x1.63+0.2x1.42-0.3x1.69-0.1x1.83+0.1x1.770.0x1.73+0.1x1.630.0x1.59
Debt-to-Equity0.380.0x0.36-0.1x0.42+0.4x0.060.0x0.08+0.1x0.020.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.000.0x0.00-0.9x0.86
FCF Margin0.5%+4.1pp-3.5%+8.5pp-12.0%-12.8pp0.8%-16.1pp16.9%-2.5pp19.3%+21.7pp-2.4%-7.2pp4.8%+5.7pp-0.9%-2.0pp1.1%+1.9pp-0.9%-1.1pp0.3%+0.6pp-0.3%-0.9pp0.6%+5.0pp-4.4%

Similar Companies

Frequently Asked Questions

What is MarineMax US's annual revenue?

MarineMax US (HZO) reported $2.3B in total revenue for fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MarineMax US's revenue growing?

MarineMax US (HZO) revenue declined by 5.0% year-over-year, from $2.4B to $2.3B in fiscal year 2025.

Is MarineMax US profitable?

No, MarineMax US (HZO) reported a net income of -$31.6M in fiscal year 2025, with a net profit margin of -1.4%.

MarineMax US (HZO) reported diluted earnings per share of -$1.43 for fiscal year 2025. This represents a -186.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MarineMax US (HZO) had EBITDA of $83.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, MarineMax US (HZO) had $170.4M in cash and equivalents against $356.2M in long-term debt.

MarineMax US (HZO) had a gross margin of 32.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

MarineMax US (HZO) had an operating margin of 1.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

MarineMax US (HZO) had a net profit margin of -1.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

MarineMax US (HZO) has a return on equity of -3.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

MarineMax US (HZO) generated $11.9M in free cash flow during fiscal year 2025. This represents a 113.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

MarineMax US (HZO) generated $72.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

MarineMax US (HZO) had $2.5B in total assets as of fiscal year 2025, including both current and long-term assets.

MarineMax US (HZO) invested $60.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, MarineMax US (HZO) spent $27.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

MarineMax US (HZO) had 22M shares outstanding as of fiscal year 2025.

MarineMax US (HZO) had a current ratio of 1.20 as of fiscal year 2025, which is considered adequate.

MarineMax US (HZO) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

MarineMax US (HZO) had a return on assets of -1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

MarineMax US (HZO) has an Altman Z-Score of 1.95, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

MarineMax US (HZO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

MarineMax US (HZO) reported a net loss of $31.6M while generating $72.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

MarineMax US (HZO) has an interest coverage ratio of 0.48x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

MarineMax US (HZO) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top